Medistim ASA (LON:0OCD)

Market Cap	452.68M +37.0%
Revenue (ttm)	62.52M +19.1%
Net Income	14.01M +25.3%
EPS	0.77 +25.2%
Shares Out	n/a
PE Ratio	32.31
Forward PE	27.75
Dividend	0.82 (3.30%)
Ex-Dividend Date	Oct 27, 2026

Volume	1
Open	315.00
Previous Close	313.00
Day's Range	315.00 - 315.00
52-Week Range	187.00 - 329.00
Beta	0.88
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 159
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0OCD

Financial Performance

In 2025, Medistim ASA's revenue was 699.77 million, an increase of 24.38% compared to the previous year's 562.60 million. Earnings were 159.21 million, an increase of 53.33%.

Financial numbers in NOK

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error